451 related articles for article (PubMed ID: 17728329)
1. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus.
Jiménez S; Tàssies D; Espinosa G; García-Criado A; Plaza J; Monteagudo J; Cervera R; Reverter JC
Ann Rheum Dis; 2008 Jun; 67(6):835-40. PubMed ID: 17728329
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes.
Pellitero S; Reverter JL; Tàssies D; Pizarro E; Monteagudo J; Salinas I; Aguilera E; Sanmartí A; Reverter JC
Thromb Haemost; 2010 Mar; 103(3):630-7. PubMed ID: 20076847
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
Borisov EN; Krasnova TN; Samohodskaia LM; Ivanitskiĭ LV; Nikiforova NV; Mukhin NA
Ter Arkh; 2014; 86(6):57-62. PubMed ID: 25095657
[TBL] [Abstract][Full Text] [Related]
4. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
Jiménez S; García-Criado MA; Tàssies D; Reverter JC; Cervera R; Gilabert MR; Zambón D; Ros E; Bru C; Font J
Rheumatology (Oxford); 2005 Jun; 44(6):756-61. PubMed ID: 15757967
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
6. The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome.
Yonal I; Hindilerden F; Hancer VS; Artim-Esen B; Daglar A; Akadam B; Nalcaci M; Diz-Kucukkaya R
Thromb Res; 2012 Apr; 129(4):486-91. PubMed ID: 22036125
[TBL] [Abstract][Full Text] [Related]
7. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia.
Macchi L; Rispal P; Clofent-Sanchez G; Pellegrin JL; Nurden P; Leng B; Nurden AT
Br J Haematol; 1997 Aug; 98(2):336-41. PubMed ID: 9266930
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
[TBL] [Abstract][Full Text] [Related]
9. [Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels].
Khaspekova SG; Ziuriaev IT; Iakushkin VV; Naĭmushin IaA; Sirotkina OV; Zaĭtseva NO; Ruda MIa; Mazurov AV
Biomed Khim; 2014; 60(1):94-108. PubMed ID: 24749250
[TBL] [Abstract][Full Text] [Related]
10. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
11. Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?
Sucker C; Schmitz M; Hetzel GR; Grabensee B; Maruhn-Debowski B; Ostojic L; Scharf RE; Zotz RB
Clin Appl Thromb Hemost; 2009; 15(4):402-7. PubMed ID: 18502778
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Gushiken FC; Arnett FC; Ahn C; Thiagarajan P
Arthritis Rheum; 1999 Jun; 42(6):1189-93. PubMed ID: 10366111
[TBL] [Abstract][Full Text] [Related]
14. Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus.
Plasín-Rodríguez MA; Patricio P; Monteagudo J; García-Criado A; Cervera R; Reverter JC; Espinosa G; Tàssies D
J Thromb Thrombolysis; 2021 Jul; 52(1):30-41. PubMed ID: 33011897
[TBL] [Abstract][Full Text] [Related]
15. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
17. Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.
Manger K; Repp R; Jansen M; Geisselbrecht M; Wassmuth R; Westerdaal NA; Pfahlberg A; Manger B; Kalden JR; van de Winkel JG
Ann Rheum Dis; 2002 Sep; 61(9):786-92. PubMed ID: 12176802
[TBL] [Abstract][Full Text] [Related]
18. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
Chen CH; Lo YK; Ke D; Liu CK; Liou CW; Wu HL; Lai ML;
J Neurol Sci; 2004 Dec; 227(1):1-5. PubMed ID: 15546585
[TBL] [Abstract][Full Text] [Related]
19. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
Vlachoyiannopoulos PG; Kanellopoulos PG; Ioannidis JP; Tektonidou MG; Mastorakou I; Moutsopoulos HM
Rheumatology (Oxford); 2003 May; 42(5):645-51. PubMed ID: 12709540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
